Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a very successful treatment option for both TYpe 2 Diabetes and obesity […]

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. https://www.npr.org/2024/12/21/nx-s1-5236098/zepbound-sleep-apnea-approved-fda The Food […]

Non-alcoholic fatty liver disease (NAFLD) is the most frequent liver disease, as it affects nearly 70% of patients with diabetes. Thus far […]

Research from Eli Lilly presented at the 2024 Annual Meeting of The European Association for the Study of Diabetes showed […]

A study just published in JAMA Internal Medicine https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821080 showed that a greater weight loss occurred for study subjects who used Tirzepatide (Mounjaro or […]

WEIGHT LOSS MEDICATIONS REDUCE COLON CANCER RISK Newly completed research published in the scientific journal JAMA Oncology (Journal of the […]

ZEPBOUND : THE NEW WEIGHT LOSS MEDICATION The FDA has just published a news release regarding its approval of Zepbound […]

A comparison of two drugs used to treat type 2 diabetes found that tirzepatide (Mounjaro) was superior to semaglutide (Ozempic) at blood […]

Polycystic Ovarian Syndrome (PCOS) is a condition of hormonal imbalance that is characterized by menstrual cycle irregularity, weight gain, fertility problems, […]

Tirzepatide Tirzepatide (Mounjaro) ia a once weekly GIP (glocose-dependent insulinoptropic polypeptide0 receptor and GLP-1 (glucagon-like peptide-1) receptor agonist. Tirzepatide activates the body’s receptors […]